|
Atomistry » Potassium » PDB 8fol-8hze » 8gng | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Potassium » PDB 8fol-8hze » 8gng » |
Potassium in PDB 8gng: Crystal Structure of Human Adenosine A2A Receptor in Complex with Istradefylline.Protein crystallography data
The structure of Crystal Structure of Human Adenosine A2A Receptor in Complex with Istradefylline., PDB code: 8gng
was solved by
M.Suzuki,
J.Saito,
H.Miyagi,
M.Yasunaga,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 8gng:
The structure of Crystal Structure of Human Adenosine A2A Receptor in Complex with Istradefylline. also contains other interesting chemical elements:
Potassium Binding Sites:
The binding sites of Potassium atom in the Crystal Structure of Human Adenosine A2A Receptor in Complex with Istradefylline.
(pdb code 8gng). This binding sites where shown within
5.0 Angstroms radius around Potassium atom.
In total 2 binding sites of Potassium where determined in the Crystal Structure of Human Adenosine A2A Receptor in Complex with Istradefylline., PDB code: 8gng: Jump to Potassium binding site number: 1; 2; Potassium binding site 1 out of 2 in 8gngGo back to![]() ![]()
Potassium binding site 1 out
of 2 in the Crystal Structure of Human Adenosine A2A Receptor in Complex with Istradefylline.
![]() Mono view ![]() Stereo pair view
Potassium binding site 2 out of 2 in 8gngGo back to![]() ![]()
Potassium binding site 2 out
of 2 in the Crystal Structure of Human Adenosine A2A Receptor in Complex with Istradefylline.
![]() Mono view ![]() Stereo pair view
Reference:
Y.Ohno,
M.Suzuki,
H.Asada,
T.Kanda,
M.Saki,
H.Miyagi,
M.Yasunaga,
C.Suno,
S.Iwata,
J.I.Saito,
S.Uchida.
In Vitro Pharmacological Profile of Kw-6356, A Novel Adenosine A 2A Receptor Antagonist/Inverse Agonist. Mol.Pharmacol. 2023.
Page generated: Sat Aug 9 16:59:35 2025
ISSN: ESSN 1521-0111 PubMed: 36894319 DOI: 10.1124/MOLPHARM.122.000633 |
Last articlesMg in 4FE1Mg in 4FBY Mg in 4FI4 Mg in 4FIG Mg in 4FI1 Mg in 4FI3 Mg in 4FHX Mg in 4FHY Mg in 4FHV Mg in 4FHW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |